Anti-CD3 monoclonal antibody

This page covers all Anti-CD3 monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD3.

Targets

CD3

Phase 2 pipeline (1)

• Foralumab Nasal · Tiziana Life Sciences LTD · Autoimmune diseases
  Foralumab Nasal is an anti-CD3 monoclonal antibody that modulates the immune system.